Methods and preparations for treating disorders of the eye and/or causing posterior vitreous disconnection or disinsertion. Preparations containing a) urea, b) urea derivatives (e.g., hydroxyurea, thiourea), c) a non-steroidal anti-inflamatory agents, d) antmetabolites, e) urea, urea derivatives, non-enzymatic proteins, nucleosides, nucleotides and their derivatives (e.g., adenine, adenosine, cytosine, cytadine, guanine, guanitadine, guanidinium, thymidine, thimitadine, uradine, uracil, cystine), uric acid, calcium acetal salicylate, ammonium sulfate or other compound capable of causing non-enzymatic dissolution of the hyaloid membrane or e) any of the possible combinations thereof, are administered to the eye in therapeutically effective amounts.

Métodos y preparaciones para los desórdenes que tratan del ojo y/o de causar la desconexión o el disinsertion vítrea posterior. Las preparaciones que contienen a) la urea, b) los derivados de la urea (e.g., hydroxyurea, thiourea), c) los agentes anti-inflamatory no-non-steroidal, d) los antmetabolites, e) la urea, los derivados de la urea, las proteínas non-enzymatic, los nucleosides, los nucleotides y los sus derivados (e.g., adenina, adenosina, cytosine, cytadine, guanine, guanitadine, guanidinium, thymidine, thimitadine, uradine, uracil, cystine), el ácido úrico, el salicylate del acetal del calcio, el sulfato del amonio o el otro compuesto capaces de causar la disolución non-enzymatic de la membrana hyaloid o e) cualquiera de las combinaciones posibles de eso, se administran al ojo en cantidades terapéutico eficaces.

 
Web www.patentalert.com

< (none)

< Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery

> Heterocyclic-hydroxyimino-fluorene nuclei compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

> (none)

~ 00046